Document is current

Article History

Accepted: 8 February 2026

First Online: 12 March 2026

Declarations

:

: Sandesh Sahebrao Patil, Brijesh Jerambhai Patel, Bhavsar Neel Mahendrabhai, C. L. Nawal, B. Valya, K. Sanjeev Kumar, Pandurang Wattamwar, Rana Kaushikkumar Ramanlal, and Swagat Shah received funding from Sun Pharma Laboratories Limited for the conduct of the study. Mandodari Rajurkar, Supriya Sonowal, Dipak Patil, Pravin Ghadge, and Suyog Mehta were full-time employees of Sun Pharma Laboratories Limited during the conduct of the study. No other potential conflicts of interest were reported by the authors.

: The study protocol, statistical analysis plan, and additional data supporting the findings of this study are available on reasonable request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

: Ethics approvals were obtained from respective institutional ethics committees at each site, including Shree Siddhivinayak Hospital Ethics Committee (ECR/1247/Inst/MH/2019); Hi-Tech Ethics Committee (ECR/1057/Inst/GJ/2018/RR-21); Institutional Ethics Committee, NHLIEC Smt. NHL Municipal Medical College (ECR/245/Inst/GJ/2013/RR-19); Ethics Committee, S.M.S. Medical College and Attached Hospitals (ECR/26/Inst/RJ/2013/RR-19); Institutional Ethics Committee, Gandhi Medical College and Hospital (ECR/180/Inst/AP/2013/RR-19); Institutional Ethics Committee, Govt. Medical College and Govt. General Hospital (ECR/492/Inst/AP/2013/RR-20); Oriion Citicare Hospital Institutional Ethics Committee (ECR/1548/Inst/MH/2021); Anand Institutional Ethics Committee (ECR/725/Inst/GJ/2015/RR-21); and Riddhi Medical Nursing Home Institutional Ethics Committee (ECR/886/Inst/GJ/2016/RR-19).

: To receive the fixed-dose combination of pregabalin prolonged release and etoricoxib during the study, eligible patients were required to provide written informed consent. The patients were informed about the study treatment and the scope of the study, and informed consent was obtained from all participants before the screening procedure.

: Not applicable.

: Not applicable.

: Sandesh Sahebrao Patil, Brijesh Jerambhai Patel, Bhavsar Neel Mahendrabhai, C. L. Nawal, B. Valya, K. Sanjeev Kumar, Pandurang Wattamwar, Rana Kaushikkumar Ramanlal, and Swagat Shah served as study investigators. They were involved in the acquisition of data, critical review of the manuscript, and gave final approval of the version to be published. Mandodari Rajurkar, Supriya Sonowal, Dipak Patil, Pravin Ghadge, and Suyog Mehta were full-time employees of Sun Pharma Laboratories Limited at the time of the study. They contributed to the interpretation of data and critically reviewed the manuscript for important intellectual content. All authors agree to be accountable for all aspects of the work and ensure the accuracy and integrity of the manuscript. All authors read and approved the final version.